EP Patent

EP0081756A1 — New compounds with antiinflammatory and antitussive activity, process for their preparation and relative pharmaceutical compositions

Assigned to Medea Research SRL · Expires 1983-06-22 · 43y expired

What this patent protects

N-Pyridil-amides of 1-phenyl-cyclopentancarboxylic acid having formula (I) wherein Py is the pyridine ring, eventually substituted with one or more methyl groups or chlorine atoms, endowed with interesting antiinflammatory and antitussive properties, and a process for the pr…

USPTO Abstract

N-Pyridil-amides of 1-phenyl-cyclopentancarboxylic acid having formula (I) wherein Py is the pyridine ring, eventually substituted with one or more methyl groups or chlorine atoms, endowed with interesting antiinflammatory and antitussive properties, and a process for the preparation thereof.

Drugs covered by this patent

Patent Metadata

Patent number
EP0081756A1
Jurisdiction
EP
Classification
—
Expires
1983-06-22
Drug substance claim
No
Drug product claim
No
Assignee
Medea Research SRL
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.